Select language:
RUS
ENG
About us
Services
Attorneys & Lawyers
Our offices
Filing requirements
IP legislation
Publications
IP legislation & Russian market news
Q & A
IP legislation & Russian market news
IP Legislation News
Russian market news
Russian market news
American companies increase their presence on the Russian market of clinical trials of new medicines
“Stada” (Germany) to invest in 2007-2008 USD 15 million in production upgrading of their affiliated company “Nizhfarm”(Russia)
“Avgol” (Israel) to build in Tula region a plant for making non-woven materials for hygienic purposes
Russian-Indian Joint Venture for drugs production to be established
“Polpharma” (Poland) purchased one of the largest pharmaceutical plants in Russia
Russia became member of “European Pharmacopoeia”
“Tatchimpharmpreparations”(Russsia) to start construction of two new shops
“Chemopharm” (Serbia) commissioned the first stage of their pharmaceutical plant in Kaluga region
“Protech” (Russia) to master production of new anti-biotics according to American know-how
“Pharmasynthesis” (Russia) to create its own production base
“Bioton” (Poland) claims almost one third of Russian insulin market
“Servier” (France) started construction of their own pharmaceutical plant in Moscow region
Russia practically has no domestic insulin
“Bioton”(Poland) to build in 2007 in Russia their own plant for making insulin
Commissioning of new Russian pharmaceutical plant to be completed in Novosibirsk
“JB Chemicals & Pharmaceuticals”(India) to open its sub-division in Moscow
Fast growth of drug consumption in Russia
“CIA International” to start own production of pharmaceuticals in Russia
“Saint-Gobain”(France) re-creates production of flasks for cosmetics and perfumery
Russia to start production of vaccine against avian flu
“Georgia-Pacific” (USA, Finland) plans to build plant for making sanitary-hygienic articles in Tver region
Production of perfumery and cosmetics under “L’Oreal” brand to be started in Russia
“Amway”(USA) – USD8 million investments for winning grounds in the Russian market of perfumery and cosmetics
The most technically modern pharmaceutical plant built near Moscow
“HTC” to be engaged in production of biologically active additives (BAD) in Russia
“Crasfarma” (Russia) to master bicyllin production
Simplified licensing for production of foreign-made formulations in Russia
Russian market of medicaments in 2003
Production line for making probiotics according to GMP standards commissioned in Russia for the first time
“Polpharma”(Poland) going to acquire “Nizhfarm” (Russia)
“EBRD” to grant ˆ22 million credit for the construction of pharmaceutical plant in Russia
“Chemopharm” to build pharmaceutical plant in Obninsk
“Akrikhin” gets the right to distribute “Venter” preparation
"Gorodissky & Partners"
B. Spasskaya Str., 25, stroenie 3, Moscow 129090, Russia
Phone: 7 (495) 937 6116 / 6109 Fax: 7 (495) 937 6104 / 6123
E-mail:
pat@gorodissky.ru
,
http://www.gorodissky.com
